RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Establishment Labs Holdings Stock

Establishment Labs Holdings Revenue 2024

Establishment Labs Holdings Revenue

169.8 M USD

Ticker

ESTA

ISIN

VGG312491084

WKN

A2JRE4

In 2024, Establishment Labs Holdings's sales reached 169.8 M USD, a 2.81% difference from the 165.15 M USD sales recorded in the previous year.

The Establishment Labs Holdings Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2028e513.4220,84
2027e421.1125,40
2026e262.3640,77
2025e210.4650,83
2024e169.863,00
2023165.1564,78
2022161.765,92
2021126.767,40
202084.761,98
201989.661,27
201861.258,99
201734.751,01
201619.851,01
20159.652,08

Establishment Labs Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Establishment Labs Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Establishment Labs Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Establishment Labs Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Establishment Labs Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Establishment Labs Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Establishment Labs Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Establishment Labs Holdings’s growth potential.

Establishment Labs Holdings Revenue, EBIT and net profit per share

DateEstablishment Labs Holdings RevenueEstablishment Labs Holdings EBITEstablishment Labs Holdings Net Income
2028e513.42 M undefined93.59 M undefined43.13 M undefined
2027e421.11 M undefined69.21 M undefined34.84 M undefined
2026e262.36 M undefined-8.95 M undefined-29.02 M undefined
2025e210.46 M undefined-24.58 M undefined-51.99 M undefined
2024e169.8 M undefined-39.55 M undefined-70.06 M undefined
2023165.15 M undefined-65.03 M undefined-78.5 M undefined
2022161.7 M undefined-39.7 M undefined-75.2 M undefined
2021126.7 M undefined-25.1 M undefined-41.1 M undefined
202084.7 M undefined-27.9 M undefined-38.1 M undefined
201989.6 M undefined-30.9 M undefined-38.2 M undefined
201861.2 M undefined-23.9 M undefined-21.1 M undefined
201734.7 M undefined-20 M undefined-34.9 M undefined
201619.8 M undefined-15.8 M undefined-22.2 M undefined
20159.6 M undefined-400,000 undefined-1.6 M undefined

Establishment Labs Holdings stock margins

The Establishment Labs Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Establishment Labs Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Establishment Labs Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Establishment Labs Holdings's sales revenue. A higher gross margin percentage indicates that the Establishment Labs Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Establishment Labs Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Establishment Labs Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Establishment Labs Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Establishment Labs Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Establishment Labs Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Establishment Labs Holdings Margin History

Establishment Labs Holdings Gross marginEstablishment Labs Holdings Profit marginEstablishment Labs Holdings EBIT marginEstablishment Labs Holdings Profit margin
2028e64.78 %18.23 %8.4 %
2027e64.78 %16.43 %8.27 %
2026e64.78 %-3.41 %-11.06 %
2025e64.78 %-11.68 %-24.7 %
2024e64.78 %-23.29 %-41.26 %
202364.78 %-39.37 %-47.53 %
202265.92 %-24.55 %-46.51 %
202167.4 %-19.81 %-32.44 %
202061.98 %-32.94 %-44.98 %
201961.27 %-34.49 %-42.63 %
201858.99 %-39.05 %-34.48 %
201751.01 %-57.64 %-100.58 %
201651.01 %-79.8 %-112.12 %
201552.08 %-4.17 %-16.67 %

Establishment Labs Holdings Aktienanalyse

What does Establishment Labs Holdings do?

Establishment Labs Holdings Inc. is a leading medical device manufacturer based in Costa Rica. The company was founded in 2004 by Juan José Chacón and Salvador Dada and has experienced strong growth since then. It is listed on the NASDAQ under the ticker ESTA since 2018. The company focuses on the development and manufacture of products that help women improve their beauty and health. Some of the most commonly offered products by Establishment Labs include breast implants, botulinum toxin injections, and hyaluronic acid fillers. These products are used by doctors and plastic surgeons worldwide. Establishment Labs' business model is based on the development of innovative products that adhere to the highest quality standards. The company invests heavily in research and development to ensure that its products are safe and effective. It also pursues a differentiated strategy to stand out from other providers. Most competitors have products that are based on leak-prone cohesive silicone gels or non-cohesive saline solutions. However, Establishment Labs has developed a patented technology based on ultra-cohesive silicone gels, which are supposed to be softer and have a lower leakage rate. The company is divided into two main segments: the breast implant market and the disposable injection market. In the breast implant market, Establishment Labs is a significant competitor to breast implant market leaders such as Allergan and Mentor. The company has also started entering the disposable injection market, focusing on the development of hyaluronic acid fillers. Establishment Labs' breast implants are manufactured under the name Motiva. Motiva implants are available in over 60 countries worldwide. They feature a variety of functions aimed at improving the health and comfort of patients. Some notable features include a nano-textured surface that allows for better integration; a circumferential self-sealing technology that offers higher resistance to ruptures and air inclusion and higher breaking recovery capacity; and a "TrueMonobloc" technology that enables implants made consistently from a single material, reducing the risk of contamination, capsular contracture, and ruptures. Establishment Labs has also recently introduced a custom 3D printer system that allows surgeons to customize the shape and size of breast implants for each patient. The disposable injection market is also a significant growth area for Establishment Labs. The company has recently acquired the license to sell Q-Med products in Mexico and is currently developing its own hyaluronic acid-based filler. The company also plans to enter the market for botulinum toxin injections in the future. Overall, Establishment Labs is an emerging medical technology company that focuses on the development of high-quality products for aesthetic surgery. The company has a strong research and development department and a differentiated strategy that allows it to stand out from the competition and establish a strong presence in a growing market. Establishment Labs Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Establishment Labs Holdings's Sales Figures

The sales figures of Establishment Labs Holdings originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Establishment Labs Holdings’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Establishment Labs Holdings's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Establishment Labs Holdings’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Establishment Labs Holdings stock

How much revenue did Establishment Labs Holdings generate this year?

Establishment Labs Holdings has achieved a revenue of 169.8 M USD this year.

How much was the turnover of the company Establishment Labs Holdings compared to the previous year?

The revenue of Establishment Labs Holdings has increased by 2.81% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Establishment Labs Holdings?

The revenue of Establishment Labs Holdings is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Establishment Labs Holdings measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Establishment Labs Holdings so important for investors?

The revenue of Establishment Labs Holdings is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Establishment Labs Holdings pay?

Over the past 12 months, Establishment Labs Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Establishment Labs Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Establishment Labs Holdings?

The current dividend yield of Establishment Labs Holdings is .

When does Establishment Labs Holdings pay dividends?

Establishment Labs Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Establishment Labs Holdings?

Establishment Labs Holdings paid dividends every year for the past 0 years.

What is the dividend of Establishment Labs Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Establishment Labs Holdings located?

Establishment Labs Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Establishment Labs Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Establishment Labs Holdings from 12/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/2/2024.

When did Establishment Labs Holdings pay the last dividend?

The last dividend was paid out on 12/2/2024.

What was the dividend of Establishment Labs Holdings in the year 2023?

In the year 2023, Establishment Labs Holdings distributed 0 USD as dividends.

In which currency does Establishment Labs Holdings pay out the dividend?

The dividends of Establishment Labs Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Establishment Labs Holdings

Our stock analysis for Establishment Labs Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Establishment Labs Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.